MCID: CHR008
MIFTS: 46

Choroiditis

Categories: Rare diseases, Eye diseases

Aliases & Classifications for Choroiditis

MalaCards integrated aliases for Choroiditis:

Name: Choroiditis 12 76 53 44 15 73

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases


External Ids:

Disease Ontology 12 DOID:11406
ICD10 33 H30.9
MeSH 44 D002833
NCIt 50 C35111
SNOMED-CT 68 16553002 193449000
UMLS 73 C0008526

Summaries for Choroiditis

MalaCards based summary : Choroiditis is related to central serous chorioretinopathy and posterior uveitis. An important gene associated with Choroiditis is ARMS2 (Age-Related Maculopathy Susceptibility 2), and among its related pathways/superpathways are Interleukin-10 signaling and Malaria. The drugs Dexamethasone and Hormone Antagonists have been mentioned in the context of this disorder. Affiliated tissues include retina, eye and endothelial.

Wikipedia : 76 Chorioretinitis is an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina... more...

Related Diseases for Choroiditis

Diseases related to Choroiditis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 869)
# Related Disease Score Top Affiliating Genes
1 central serous chorioretinopathy 33.0 ARMS2 CFH
2 posterior uveitis 32.1 CFH TNF
3 punctate inner choroidopathy 31.6 IL10 TNF
4 panuveitis 31.4 IL10 TNF
5 retinal disease 30.6 ARMS2 CFB CFH
6 multifocal choroiditis 30.0 ARMS2 CFB CFH HTRA1 IL10 TNF
7 intermediate uveitis 30.0 IL10 TNF
8 eales disease 29.9 IL10 TNF
9 macular degeneration, age-related, 1 29.9 ARMS2 CFB CFH HTRA1 TNF
10 lyme disease 29.7 CFH TNF
11 membranoproliferative glomerulonephritis 29.6 CFB CFH
12 prostatitis 29.4 IL10 TNF
13 toxoplasmosis 29.4 IL10 TNF
14 cytomegalovirus infection 28.8 IL10 TNF
15 complex regional pain syndrome 28.7 IL10 TNF
16 chlamydia 28.7 IL10 TNF
17 allergic contact dermatitis 28.6 IL10 TNF
18 rubella 28.6 IL10 TNF
19 degeneration of macula and posterior pole 28.6 ARMS2 CFB CFH HTRA1
20 contact dermatitis 28.5 IL10 TNF
21 toxic shock syndrome 28.4 IL10 TNF
22 peritonitis 28.2 IL10 TNF
23 choroidal dystrophy, central areolar, 1 12.5
24 papilloma of choroid plexus 12.5
25 gyrate atrophy of choroid and retina 12.4
26 choroid plexus cancer 12.4
27 choroid disease 12.4
28 serpiginous choroiditis 12.3
29 choroid plexus cyst 12.2
30 choroidal dystrophy, central areolar 2 12.2
31 ataxia - hypogonadism - choroidal dystrophy 12.1
32 choroid spindle cell melanoma 12.1
33 hereditary choroidal atrophy 12.1
34 atypical choroid plexus papilloma 12.0
35 choroid plexus meningioma 12.0
36 malignant choroid melanoma 12.0
37 choroidal osteoma, bilateral 12.0
38 choroid necrotic melanoma 12.0
39 choroideremia 11.9
40 choroidal dystrophy, central areolar, 3 11.9
41 birdshot chorioretinopathy 11.9
42 adult choroid plexus cancer 11.8
43 choroid mixed cell melanoma 11.8
44 partial central choroid dystrophy 11.8
45 childhood choroid plexus cancer 11.8
46 choroid epithelioid cell melanoma 11.8
47 partial circumpapillary choroid dystrophy 11.8
48 central gyrate choroidal dystrophy 11.8
49 total circumpapillary dystrophy of choroid 11.8
50 choroid plexus calcification and mental retardation 11.7

Graphical network of the top 20 diseases related to Choroiditis:



Diseases related to Choroiditis

Symptoms & Phenotypes for Choroiditis

Drugs & Therapeutics for Choroiditis

Drugs for Choroiditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-02-2 5743
2 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
3 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
4 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
5 Antiemetics Phase 4,Phase 3,Phase 2,Not Applicable
6 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
8 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable
9 BB 1101 Phase 4,Phase 3,Phase 2,Not Applicable
10 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Not Applicable 1177-87-3
11 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Not Applicable
12 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
13 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
14 Immunosuppressive Agents Phase 4,Phase 3,Phase 1,Phase 2
15 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
16
protease inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
17 Adrenocorticotropic Hormone Phase 4
18 beta-endorphin Phase 4
19 Melanocyte-Stimulating Hormones Phase 4
20
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
21
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
22
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
23
Pyrimethamine Approved, Investigational, Vet_approved Phase 3 58-14-0 4993
24
Sulfadiazine Approved, Investigational, Vet_approved Phase 3 68-35-9 5215
25
Bevacizumab Approved, Investigational Phase 3,Not Applicable 216974-75-3
26
Triamcinolone Approved, Vet_approved Phase 3,Phase 1,Phase 2 124-94-7 31307
27
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 3,Not Applicable 67-73-2 6215
28
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
29
Mycophenolic acid Approved Phase 3 24280-93-1 446541
30
Prednisone Approved, Vet_approved Phase 3,Phase 2 53-03-2 5865
31
Methotrexate Approved Phase 3,Phase 1,Phase 2 1959-05-2, 59-05-2 126941
32
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2 59-30-3 6037
33
leucovorin Approved, Nutraceutical Phase 3,Phase 1,Phase 2 58-05-9 143 6006
34 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
35 Anti-Infective Agents Phase 3,Phase 2,Phase 1
36 Antimalarials Phase 3
37 Antiparasitic Agents Phase 3
38 Antiprotozoal Agents Phase 3
39 Clindamycin palmitate Phase 3
40 Clindamycin phosphate Phase 3
41 Folic Acid Antagonists Phase 3,Phase 1,Phase 2
42 Methylprednisolone acetate Phase 3
43 Methylprednisolone Hemisuccinate Phase 3
44 Neuroprotective Agents Phase 3
45 Prednisolone acetate Phase 3
46 Prednisolone hemisuccinate Phase 3
47 Prednisolone phosphate Phase 3
48 Protective Agents Phase 3
49 Vitamin B Complex Phase 3,Phase 1,Phase 2
50 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show all 38)
# Name Status NCT ID Phase Drugs
1 Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Completed NCT02764697 Phase 4 H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
2 Study of the Effectiveness of Ozurdex for the Control of Uveitis Recruiting NCT02049476 Phase 4 Dexamethasone pellet
3 To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis Unknown status NCT00372294 Phase 3 pyrimethamine-sulfadiazine + prednisolone;Clindamycin+Dexamethasone
4 Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Completed NCT00407121 Phase 3 Bevacizumab
5 Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis Completed NCT03097315 Phase 3
6 A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye Completed NCT02748512 Phase 3 FAI insert
7 A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis Completed NCT00404742 Phase 3 Placebo;LX211;LX211;LX211
8 A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis Completed NCT00404612 Phase 3 Placebo;LX211;LX211;LX211
9 A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis Completed NCT00333814 Phase 2, Phase 3 Dexamethasone;dexamethasone;Sham injection
10 Myfortic for the Treatment of Non-infectious Intermediate Uveitis Completed NCT01092533 Phase 3 Myfortic;Decortin
11 Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis Completed NCT02595398 Phase 3 4mg CLS-TA Suprachoriodal Injection;Sham Procedure
12 Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis Completed NCT00344253 Phase 3 Interferon beta;Methotrexate
13 Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis Active, not recruiting NCT02746991 Phase 3 Sham Injection;FAI Insert
14 Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Active, not recruiting NCT01694186 Phase 3 FAI insert;Sham injection
15 Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy Completed NCT00470977 Phase 1, Phase 2 ranibizumab injection (0.5 mg)
16 Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis Completed NCT01789320 Phase 1, Phase 2 triamcinolone acetonide (Triesence®)
17 Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , Completed NCT01526889 Phase 2 LFG316;Conventional Therapy
18 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
19 Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis Completed NCT01552044 Phase 1, Phase 2 Spironolactone;Placebo
20 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis Completed NCT02255032 Phase 2 4 mg CLS-TA;0.8 mg CLS-TA
21 Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a Completed NCT00508040 Phase 2 interferon alpha 2a;prednisone
22 Intravitreal Sirolimus as Therapeutic Approach to Uveitis Recruiting NCT01280669 Phase 2 Intravitreal injection 440mcg;Intravitreal injection of sirolimus 880mcg
23 Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Active, not recruiting NCT01717170 Phase 1, Phase 2 Tocilizumab
24 Safety and Preliminary Efficacy Study of V404 PDS in Uveitis Terminated NCT02125266 Phase 1, Phase 2 V404
25 Safety &Efficacy of CF101 to Subjects With Uveitis Withdrawn NCT01905124 Phase 2 CF101;Placebo
26 Sirolimus as Therapeutic Approach to Uveitis Unknown status NCT00908466 Phase 1 Sirolimus (rapamycin);Sirolimus (rapamycin)
27 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Completed NCT00645697
28 Evaluation and Treatment of Patients With Inflammatory Eye Diseases Completed NCT00006188
29 Retisert and Cataract Surgery in Patients With Severe Uveitis Completed NCT00570830 Not Applicable
30 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Not Applicable Anti-toxoplasmosis treatment;Anti-inflammatory treatments
31 Quality of Life in Patients With Intermediate Uveitis Completed NCT01314469
32 A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD) Active, not recruiting NCT02941991
33 Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD Active, not recruiting NCT02463344
34 Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients Active, not recruiting NCT02445612
35 Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 Active, not recruiting NCT02952001
36 Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis Not yet recruiting NCT02879084
37 Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Withdrawn NCT01256580 Not Applicable Bevacizumab (Avastin; Genentech, Inc.);Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
38 Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes. Withdrawn NCT01151462

Search NIH Clinical Center for Choroiditis

Cochrane evidence based reviews: choroiditis

Genetic Tests for Choroiditis

Anatomical Context for Choroiditis

MalaCards organs/tissues related to Choroiditis:

41
Retina, Eye, Endothelial, Brain, Lung, Testes, Thyroid

Publications for Choroiditis

Articles related to Choroiditis:

(show top 50) (show all 2923)
# Title Authors Year
1
DETECTION OF TYPE 1 CHOROIDAL NEOVASCULAR MEMBRANES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN TUBERCULAR POSTERIOR UVEITIS. ( 29689028 )
2018
2
Assessment of the macula and choroid in pediatric keratoconus patients. ( 29942181 )
2018
3
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy. ( 29411259 )
2018
4
The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. ( 29671064 )
2018
5
Chromatic and achromatic visual fields in relation to choroidal thickness in patients with high myopia: A pilot study. ( 29396209 )
2018
6
Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis. ( 29669371 )
2018
7
A Case of Vago-Glossopharyngeal Neuralgia Caused by Choroid Plexus. ( 29682078 )
2018
8
Optical Coherence Tomography Features of Tuberculous Serpiginous-like Choroiditis and Serpiginous Choroiditis. ( 29866214 )
2018
9
Multimodal Imaging of Post-Infectious Unilateral Outer Retinopathy and Choroiditis. ( 29953300 )
2018
10
Clinical Features of Central Serous Chorioretinopathy with Type 1 Choroidal Neovascularization. ( 29940168 )
2018
11
Comparison of hydrocephalus metrics between infants successfully treated with endoscopic third ventriculostomy with choroid plexus cauterization and those treated with a ventriculoperitoneal shunt: a multicenter matched-cohort analysis. ( 29393809 )
2018
12
EDI OCT evaluation of choroidal thickness in Stargardt disease. ( 29304098 )
2018
13
Transition metals and trace elements in the retinal pigment epithelium and choroid: correlative ultrastructural and chemical analysis by analytical electron microscopy and nano-secondary ion mass spectrometry. ( 29327028 )
2018
14
Correction: The absence that makes the difference: choroidal abnormalities in Legius syndrome. ( 29479078 )
2018
15
A case of a mobile choroid plexus cyst presenting with different types of obstructive hydrocephalus. ( 29541488 )
2018
16
<i>CFH</i> and <i>VIPR2</i> as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. ( 29844195 )
2018
17
CHORIOCAPILLARIS FLOW VOIDS IN CRYPTOCOCCAL CHOROIDITIS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. ( 29373342 )
2018
18
Optical Coherence Tomography Microangiography Imaging of Circumscribed Choroidal Hemangioma. ( 29443364 )
2018
19
Retinal and Choroidal Microvasculature in Nonarteritic Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study. ( 29490340 )
2018
20
Bone inside eye: choroidal osteoma presenting as exudative retinal detachment: a challenge to diagnosis. ( 29914906 )
2018
21
Reticular Pseudodrusen and Thin Choroid Are Associated With Angioid Streaks. ( 29927467 )
2018
22
Multimodal Imaging to Monitor Recurrent Serpiginous Choroiditis. ( 29937127 )
2018
23
Enhanced Depth Imaging by High-Resolution Spectral Domain Optical Coherence Tomography in Tubercular Multifocal Serpiginoid Choroiditis. ( 29787321 )
2018
24
Choroidal thickness changes following cataract surgery using swept source optical coherence tomography. ( 29426443 )
2018
25
Swept-source optical coherence tomography study of choroidal morphology in Stargardt disease. ( 29930450 )
2018
26
Syringomyelia with intramedullary ectopic choroid plexus: Case report. ( 29609116 )
2018
27
A unique presentation of an adolescent with disseminated atypical choroid plexus papilloma. ( 29770898 )
2018
28
Is Nonarteritic Ischemic Optic Neuropathy Due to Choroidal Compression of the Prelaminar Neurovascular Compartment of the Optic Nerve Head? ( 29438261 )
2018
29
Choroidal Thickness in Diabetic Macular Edema Compared to Normal Controls. ( 29944846 )
2018
30
Correlation of subfoveal choroidal thickness with axial length, refractive error, and age in adult highly myopic eyes. ( 29843668 )
2018
31
Assessment of measurement methods of posterior inflammation in stromal choroiditis: the value of quantitative outcome measures versus the presently qualitatively based paradigm. ( 29946830 )
2018
32
A recurrent de novo missense pathogenic variant in SMARCB1 causes severe intellectual disability and choroid plexus hyperplasia with resultant hydrocephalus. ( 29907796 )
2018
33
Early Retinal and Choroidal Coat Thickness Changes After Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema. ( 29866639 )
2018
34
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis. ( 29566868 )
2018
35
Revisiting pleuropulmonary blastoma and atypical choroid plexus in a young child: DICER1 syndrome or not? ( 29943907 )
2018
36
INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH MORNING GLORY SYNDROME. ( 29324624 )
2018
37
Long-term results of intravitreal bevacizumab and dexamethasone for the treatment of punctate inner choroidopathy associated with choroidal neovascularization: A case series. ( 29760922 )
2018
38
Macular Choroidal Thickening in Keratoconus Patients: Swept-Source Optical Coherence Tomography Study. ( 29888113 )
2018
39
TREATMENT OF REFRACTORY TUBERCULAR SERPIGINOUS-LIKE CHOROIDITIS WITH INTRAVITREAL METHOTREXATE. ( 29979252 )
2018
40
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy. ( 29619248 )
2018
41
Treatment of choroidal neovascularization in a case of factor VIII deficiency: Ten-year follow-up. ( 29977729 )
2018
42
Clinicopathologic Features of Tuberculous Serpiginous-like Choroiditis. ( 29270629 )
2018
43
Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome. ( 29403070 )
2018
44
Choroidal perfusion abnormalities associated with Acute Posterior Multifocal Placoid Pigment Epitheliopathy: a case report. ( 29631552 )
2018
45
Pathway analysis identifies altered mitochondrial metabolism, neurotransmission, structural pathways and complement cascade in retina/RPE/ choroid in chick model of form-deprivation myopia. ( 29967729 )
2018
46
Risk Factors for Developing Choroidal Neovascular Membrane and Visual Loss in Punctate Inner Choroidopathy. ( 28993011 )
2018
47
PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis. ( 29304262 )
2018
48
Atypical posterior scleritis mimicking choroidal melanoma. ( 29738013 )
2018
49
Cryptococcal choroiditis in advanced AIDS with clinicopathologic correlation. ( 29780913 )
2018
50
Optical coherence tomography angiography and choroidal neovascularization in multifocal choroiditis: A descriptive study. ( 29569477 )
2018

Variations for Choroiditis

Expression for Choroiditis

Search GEO for disease gene expression data for Choroiditis.

Pathways for Choroiditis

Pathways related to Choroiditis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.06 IL10 TNF
2 11.01 IL10 TNF
3 10.8 IL10 TNF
4 10.7 IL10 TNF
5 10.55 CFB CFH IL10
6 10.43 IL10 TNF

GO Terms for Choroiditis

Cellular components related to Choroiditis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.35 CFB CFH HTRA1 IL10 TNF
2 extracellular space GO:0005615 9.02 CFB CFH HTRA1 IL10 TNF

Biological processes related to Choroiditis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 response to glucocorticoid GO:0051384 9.49 IL10 TNF
2 positive regulation of vascular smooth muscle cell proliferation GO:1904707 9.48 IL10 TNF
3 negative regulation of mitotic cell cycle GO:0045930 9.46 IL10 TNF
4 positive regulation of cytokine secretion GO:0050715 9.43 IL10 TNF
5 negative regulation of interleukin-6 production GO:0032715 9.4 IL10 TNF
6 negative regulation of growth of symbiont in host GO:0044130 9.37 IL10 TNF
7 complement activation, alternative pathway GO:0006957 9.32 CFB CFH
8 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.26 IL10 TNF
9 endothelial cell apoptotic process GO:0072577 9.16 IL10 TNF
10 negative regulation of cytokine secretion involved in immune response GO:0002740 8.96 IL10 TNF
11 receptor biosynthetic process GO:0032800 8.62 IL10 TNF

Sources for Choroiditis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....